Amyotrophic lateral sclerosis (ALS) is a fatal progressive neurodegenerative disease with no known cure.
As a Schmidt Science Fellow, Lauren will use advanced mass spectrometry and protein analysis of clinical blood and cerebrospinal fluid samples from patients. By training a machine learning model with these data, Lauren aims to predict disease state from patient samples.
In the short term, Lauren’s approach will enhance understanding of ALS progression. In the long term, this approach could allow for earlier diagnosis, faster intervention, and improved care for patients living with ALS.
Lauren will pivot from Analytical Chemistry to Genetics & Genomics